Antibodies against the current influenza a (H1N1) vaccine strain do not protect some individuals from infection with contemporary circulating influenza a (H1N1) virus strains

Journal of Infectious Diseases

Volumn 214, Issue 12, 2016, Pages 1947-1951

  Petrie, Joshua G ^a   Parkhouse, Kaela ^b,c   Ohmit, Suzanne E ^a   Malosh, Ryan E ^a   Monto, Arnold S ^a   Hensley, Scott E ^b,c  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antigenic drift; Correlates of protection; Hemagglutinin; Household cohort; Influenza; Influenza vaccine; Pandemic H1N1; Serum antibody

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; HEMAGGLUTININ; INFLUENZA VACCINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HOUSEHOLD; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA A VIRUS (H1N1); MALE; NONHUMAN; PROSPECTIVE STUDY; VIRUS MUTATION; VIRUS STRAIN; BLOOD; CROSS PROTECTION; IMMUNOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CROSS PROTECTION; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 85009119753     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw479     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. Swine influenza A(H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:400-2.
2. Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
3. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27.
4. Gaglani M, Pruszynski J, Murthy K, et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States. J Infect Dis 2016; 213:1546-56.
5. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-52.
6. Centers for Disease Control and Prevention. Update: influenza activity-United States, 2009-10 season. MMWR Morb Mortal Wkly Rep 2010; 59:901-8.
7. Epperson S, Blanton L, Kniss K, et al. Influenza activity-United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep 2014; 63:483-90.
8. Linderman SL, Chambers BS, Zost SJ, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc Natl Acad Sci U S A 2014; 111:15798-803.
9. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. http://www. who. int/influenza/vaccines/virus/recommendations/201602-recommendation. pdf?ua=1. Accessed 9 May 2016.
10. Ohmit SE, Petrie JG, Malosh RE, et al. Substantial influenza vaccine effectiveness in households with children during the 2013-2014 influenza season, when 2009 pandemic influenza A(H1N1) virus predominated. J Infect Dis 2016; 213: 1229-36.
11. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg Camb 1972; 70:767-77.
12. Monto AS, Petrie JG, Cross RT, et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J Infect Dis 2015; 212:1191-9.
13. Beyer WE, Palache AM, Sprenger MJ, et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996; 14:1331-9.
14. Neher RA, Bedford T. Nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics 2015; 31:3546-8.
15. Centers for Disease Control and Prevention. Laboratory-confirmed influenza hospitalizations. http://gis. cdc. gov/GRASP/Fluview/FluHospRates. html. Accessed 9 May 2016.